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Infection after fracture osteosynthesis –
Part I: Pathogenesis, diagnosis
and classification
Christian Fang1, Tak-Man Wong1,3, Tak-Wing Lau1,
Kelvin KW To2, Samson SY Wong2, and Frankie Leung1,3
Abstract
Bone and surgical site infections after osteosynthesis are notoriously difficult to manage and pose a tremendous burden in
fracture management. In this article, we use the term osteosynthesis-associated infection (OAI) to refer to this clinical
entity. While relatively few surgically treated fractures become infected, it is challenging to perform a rapid diagnosis.
Optimal management strategies are complex and highly customized to each scenario and take into consideration the
status of fracture union, the presence of hardware and the degree of mechanical stability. At present, a high level of
relevant evidence is unavailable; most findings presented in the literature are based on laboratory work and non-
randomized clinical studies. We present this overview of OAI in two parts: an examination of recent literature con-
cerning OAI pathogenesis, diagnosis and classification and a review of treatment options.
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Introduction
The term osteosynthesis-associated infection (OAI) is
defined here as the clinical or subclinical infection of a
fracture following surgical fixation with an internally
placed implant. Prosthetic joint infection (PJI) is another
type of orthopaedic implant infection. Patients with either
OAI or PJI may present with implant-bound infections,
bone and soft tissue defects, sinuses, osteomyelitis, implant
loosening and deformities as well as various adverse micro-
biological and patient characteristics.1,2 OAI is uniquely
challenging, however, due to the presence of trauma, frac-
ture instability, non-union and the need for cartilage pre-
servation. Also, at present, there is a relative lack of
consensus among clinicians as to the proper treatment of
OAI. PJI has its challenges though effective treatment
options are better understood.3–5
While OAI is uncommon – the rate of infection after
closed fracture, for instance, is only 1–2%6 – its high com-
plexity of management makes it extremely costly to treat.
OAI management frequently involves prolonged hospital
stay, rehabilitation, repeated operations and the extensive
use of specialized investigation and treatment.7–9 As a
result, patients with OAI have high morbidity rates and are
less likely to return to duty.10 The increasingly frequent use
of internal fixation11–13 and the emergence of antibiotic-
resistant microorganisms14 have exacerbated this problem.
Risk factors
Fracture type
Open fractures are most commonly associated with OAI.
The risk of secondary infection according to the Gustilo
1Department of Orthopaedics and Traumatology, Queen Mary Hospital,
University of Hong Kong, Pokfulam, Hong Kong, China
2Department of Microbiology, Queen Mary Hospital, University of Hong
Kong, Pokfulam, Hong Kong, China
3 Shenzhen Key Laboratory for Innovative Technology in Orthopaedic
Trauma, University of Hong Kong-Shenzhen Hospital, Shenzhen, China
Corresponding author:
Christian Fang, Department of Orthopaedics and Traumatology, Queen
Mary Hospital, University of Hong Kong, 102 Pok Fu Lam Road, Hong
Kong, China.
Email: fangcx@gmail.com
Journal of Orthopaedic Surgery
25(1) 1–13
ª Journal of Orthopaedic Surgery 2017
Reprints and permissions:
sagepub.co.uk/journalsPermissions.nav
DOI: 10.1177/2309499017692712
journals.sagepub.com/home/osj
Journal ofOr thopaedic
Surger y
and Anderson grading15 is 2–4% for grades I and II, and
between 4% and 52% for class III fractures, depending on
the severity of soft tissue damage.15–20 Fractures of the
lower limbs, especially near the proximal and distal
tibia,11,17,21 are at the greatest risk.22 Severe soft tissue
involvement, polytrauma,23 penetrating, blast, combat inju-
ries10,24–26 and compartment syndrome are significant risk
factors for subsequent infection.27,28 Irradiation-related
fractures,29 pathological fractures30 and pelvic fractures
requiring arterial embolization31 are all also at increased
risk of OAI. In comparison to acute fractures, fixations of
non-unions have double the risk of infection.17
Patient risk factors
Tobacco smoking, diabetes mellitus, history of stroke,
heart failure and multiple previous operations are identified
risk factors of OAI.32–37 Immunocompromised patients can
present atypically38,39 with slow growing atypical organ-
isms40 and a combination of less fulminant initial clinical
features that lead to a delay in diagnosis but later rapidly
deteriorate into life-threatening infections.41 Elderly
patients,42–44 intravenous drug users and socially deprived
patients are also shown to be at higher risk.45 In fragility hip
fractures, both mortality and disability are increased with
OAI.34,46 HIV-infected patients are at risk of osteoporosis,
all types of fractures,47–49 infection of non-operated frac-
ture haematoma50 and OAI.51
Controllable risk factors
There is robust evidence to show that antibiotic prophylaxis
is highly effective in reducing the risk of OAI for both open
and closed fractures.15,17,52 In open fractures, the infection
risk is profoundly increased when the administration of
prophylactic antibiotics is delayed for more than 6 h.53
In open fractures, a minor delay in initial surgical deb-
ridement of more than 6 h is not associated with signifi-
cantly increased risk,54,55 but patients operated on by
inexperienced surgeons are at higher risk.56 Early closure
of the primary open wound appears to be beneficial.57–59
Prolongation of surgery is associated with infection.23,27,60
The use of plastic adhesive drapes can reduce bacterial load
at the surgical site.61 Overzealous powered reaming or
drilling causes heat necrosis.62 The risk is increased with
multiplicity and size of implants and the presence of bone
grafts, allografts or other foreign materials.63–67 Prolonged
use of surgical drains is thought to increase the risk of OAI,
but the issue remains controversial.43 Indwelling catheters
and blood transfusions may carry a small rise in the like-
lihood of infection.68–71 There is weak evidence showing
that prolonged use of external fixators for more than 28
days before internal fixation is associated with a higher
likelihood of infection.23,72,73
From a randomized study, smoking cessation effectively
halved infection and other complications.74 Routine
auditing of infection rates and clinical practice is effective
in minimizing OAI at the hospital management level.75
Pathogenesis
Microbiology
Staphylococcus aureus causes the majority of OAI cases.
Methicillin-resistant S. aureus is now more frequent than
methicillin-susceptible S. aureus in some areas and not
limited to institutionalized patients.7,34,36,76–80 OAI caused
by less virulent skin organisms, such as coagulase-negative
staphylococci (CNS), can be as frequent as S. aureus6,46
and 80–90% of CNS cases are methicillin resistant.81
Lower virulence skin flora, such as Corynebacterium82,83
and Propionibacterium,84–86 are increasingly identified as
diagnostic techniques are improved and should not be
regarded as contaminants.
Gastrointestinal tract organisms, including Escherichia
coli, Enterobacter, Enterococci, Klebsiella and Proteus,
are important causes of OAI in sites near the perineum.28
Gram-negative glucose non-fermenters, such as Pseudomo-
nas aeruginosa and Acinetobacter baumannii, are fre-
quently found both inside and outside the hospital. They
have a minimal nutritional requirement, tolerance to rela-
tively high temperature and resistant to many antibiotics.
There is an increasing frequency of infections caused by
multidrug-resistant P. aeruginosa and A. baumannii.87,88 P.
aeruginosa is associated with significantly higher recur-
rence rates and failure of control as compared with
Staphylococcus.89,90
Polymicrobial infection is linked to open fractures78,79
and poor outcome.91 Clostridium species, which is found in
the soil, and Aeromonas species, which resides in brackish
water, are highly virulent organisms associated with life-
threatening necrotizing infections, which require urgent
surgical intervention.92–97 Nontuberculous mycobacterium
and fungi are environmental organisms resistant to conven-
tional antibiotics and disinfectants and occasionally intro-
duced via open wounds.98–100 Mycobacterium
tuberculosis101,102 is rare even in endemic countries.103
When atypical slow-growing pathogens are identified, a
pre-existing bone infection, pathological fracture and an
immunocompromised state must be suspected.104–107
Biofilm formation and development
of drug resistance
At inoculation, bacteria are in planktonic form and suscep-
tible to host defence and antibiotics. Successful bacteria
initiate infection in the soft tissue and replicate rapidly.
Bone and implant involvement increase over the following
1–2 weeks characterized by osteitis, bone necrosis, reduced
the new bone formation and implant loosening. Organisms
became chronically entrenched within implant surface
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biofilm and emptied Haversian canals, becoming increas-
ingly difficult to eradicate.108
Biofilm production109 is critical to bacterial survival in
the environment, because planktonic organisms are highly
susceptible to adverse external factors. The biofilm is a
colony-like aggregation of cells embedded in an exopoly-
saccharide matrix mixed with extracellular products, firmly
attached to the surface of implants.110,111 There are five
stages in its development and maturation.112 Free-floating
planktonic microbes first adhere to metal surfaces (stage I).
In stage II, they multiply and start to produce exopolysac-
charide matrix, which retains nutrients and more planktonic
organisms. In stage III, the early biofilm architecture devel-
ops (colonization) and then matures (stage IV), wherein
microorganisms in the deeper layers become increasingly
dormant and isolated from the external environment. At the
final stage (stage V), microbes are dispersed back into the
environment to colonize other new substrates.
Biofilm-bound organisms are resistant to phagocytosis.
Macrophages that attempt to attack the biofilm may cause
more damage to the surrounding tissues. The exopolysac-
charide matrix hinders the penetration of antibiotics and
antibodies both physically and by electrostatic binding. Phy-
siological dormancy of bacterial cells makes them refractory
to antibiotics that target their metabolic and replication path-
ways.113,114 For instance, the minimal inhibitory concentra-
tion for biofilm bounded pseudomonas can increase 1000-
fold when compared to planktonic forms.111
Organisms within the biofilm can cross-communicate
and adapt. This is referred to as the quorum-sensing sys-
tem.115,116 Various virulence factors are regulated and
released to protect the biofilm from elimination. In chronic
infections, there is increased mutation and increased
genetic resistance to antibiotics and host defence.114
Small-colony variants (SCVs) are slow-growing variants
of the offending organism which tend to reside in the bio-
film and develop resistance and play a major role in persis-
tent or recurrent infections.117 Because SCVs are
overwhelmed in acute infections, they are not easily
detected using routine methods.
Implant material and design
The presence of foreign bodies impairs the host
defences.118 Macrophages accumulated around implants
are functionally defective as they become exhausted when
unable to engulf targets of excessive physical size.119 Simi-
larly, granulocytes become activated because of foreign
materials, but bacteria-targeted degranulation, ingestion
and superoxide production are all impaired.120 Materials
that are less biocompatible triggers off a more intense cyto-
kine cascade, together with adjacent tissue damage and
formation of an immune-impaired reactive capsule and a
potential space in between.121,122
Microorganism and biofilm adhesion is affected by bac-
terial, environmental and surface characteristics.123
Microrough surfaces at bacterial length scales are prone
because of increased surface area and greater resistance
to shear forces.124 Different microorganisms have different
affinity for surfaces depending on factors, such as surface
topology, chemical composition, charge, hydrophobicity
and physical configuration, as well as environmental fac-
tors, such as temperature, pH, electrolyte concentration,
flow and the presence of serum proteins and antibiotics.
The most commonly used materials are stainless steel
and titanium alloy. While stainless steel is less biocompa-
tible and more susceptible to staphylococcal infection in
animal models,121,125,126 they are typically manufactured
with a polished surface finish. Conversely, the finishing
of titanium alloy is usually anodized, and its microrough
surface favours biofilm development. In all, there is no
definite in vivo evidence to support the superiority of either
material.127
Implants with internal dead spaces, such as cannulated
open section nails, are more prone to OAI.128 Minimally
invasive plating alone does not appear to reduce infection
when compared to open surgery.129 Rather, infection is
lowered with low contact plating, because periosteal strip-
ping and disturbance to blood supply are minimized.130,131
In limited studies, absorbable polymer implants had similar
infection risk compared with metallic implants.132 There is,
however, a general concern for associated infection related
to their biocompatibility, associated tissue reaction, osteo-
lysis and retained debris.133
Infection and fracture stability
An unstable infected fracture is more problematic than a
stably infected fracture.134 Although infection is more
likely to occur in conjunction with the presence of a foreign
body, stable internal fixation of fractures appears to reduce
the likelihood of infection. In a rabbit model, osteotomies
inoculated with S. aureus were less likely to get infected
after stable internal fixation compared to unstable internal
fixation.135 Although the mechanism is still unknown, it is
believed that increased soft tissue irritation, difficulty in
revascularization,136 haematoma and evolving dead space
resulting from excess motion are all unfavorable factors of
infection.
Stability is compromised when there is the persistence
of infection for more than 2 weeks.137 Natural bone turn-
over is affected by the homeostatic balance between
osteoblast and osteoclast activities is disrupted. Surface-
associated material from staphylococci induces leukocytes
production of tumour necrosis factor alpha (TNF-a, IL-I
and IL-6 and upregulation of receptor activator of the
nuclear factor-kB (RANK) in pre-osteoclasts. Osteoclasts
are hyperactivated, and the balance is tipped against bone-
forming osteoblasts. Excessive bone is resorbed from
infected areas adjacent to the implant and the fracture,
leading to mechanical failure, instability, non-union and
persistence of infection138 (Figure 1).
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Diagnosis
Clinical
The diagnosis of OAI is usually clinical. The presentation
varies depending on the virulence of the organism, mode of
infection, condition of fracture healing and depth. The typical
features are increasing local pain, erythema, swelling, wound
breakdown, purulent discharge, sinus formation and systemic
symptoms, such as fever. For acute OAI, patients most com-
monly present in the first month after fracture fixation.139
Cast treatment can obscure local features and delay the diag-
nosis.97 Delayed infections often have less severe features as
they are often caused by low virulent microorganisms such as
CNS. Moreover, OAI manifestations may be masked because
of liberal usage of empirical antibiotic treatment.140
Imaging studies
Changes in plain radiographs usually occur late and are
therefore not useful in detecting acute infections. Patients
with delayed infections may have extensive periosteal reac-
tions, implant loosening and non-union on radiographs.139
Gas indicates severe infections or the presence of a sinus
tract if not due to recent surgery. Despite a lack of sensi-
tivity and specificity,141 routine serial radiographic
evaluations serve to provide crucial information on fracture
healing and implant stability.
Computed tomography (CT) is useful in confirming the
status of fracture healing, the presence of sequestra and
infection. Intravenous contrast enhances the visualization
of inflamed soft tissue and the rims around abscess. Soft
tissue signal findings are 100% sensitive and 87% specific
for orthopaedic implant-related infection.142 Titanium
implants are less susceptible artefacts than stainless steel.
The implant should be aligned along the axis of the gantry,
so that beam traversal is minimized. Other artefact reduc-
tion techniques include using high energy settings, narrow
collimation, thin sections and extended dynamic ranges.143
CT scans contrast sonograms are useful in evaluating deep
originating sinuses.144 Gadolinium-contrast magnetic reso-
nance imaging (MRI) scans are very prone to metallic arte-
facts but helpful in mapping out infected soft tissue and
sequestrum after implant removal.
Ultrasonography is useful for detecting collections.141
Implant and bone surfaces are highly echogenic, fluid sig-
nals are well defined and metallic artefacts are minimal
compared to CT or MRI scans. Ultrasound-guided aspira-
tion is appropriate when small collections are deeply situ-
ated. The limited acoustic window may fail to penetrate
very deep locations at the hip and pelvis in obese patients.
Figure 1. The sequence of events occurring in OAI from inoculation to establishment of infection, implant loosening and abscess
rupture at different magnifications (refer to pathogenesis). The illustration is not drawn to scale. OAI: osteosynthesis-associated
infection.
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Radionuclide scans are useful in confirming occult
implant related infections or anatomical localization of
unrecognized focus. The indium-111-labelled leukocyte
scan has a superior accuracy of 90%145 compared to
bone-gallium 67 or technetium-99m scintigraphy, because
they are prone to false positives from the effects of bone
healing, trauma, degeneration and surgery. Unfortunately,
there are some major drawbacks of leukocyte scanning.
The method is time-consuming, technically complex and
relatively expensive, typically requiring at least 2 days for
leukocyte labelling and scanning. Routine use of leukocyte
scanning to exclude infections in non-unions appears to be
less accurate and not cost-effective compared to routine
blood tests alone.146
Positron emission tomography
Until recently, 18F-fluorodeoxyglucose positron emission
tomography (FDG-PET) was primarily used for detecting
hypermetabolic malignancies. However, PET is discovered
to be increasingly useful in infections where glucose meta-
bolism is also increased. The test has a sensitivity of nearly
100% and specificity of above 90% in occult and early
musculoskeletal infections, including OAI. Since 2010, the
European Medicines Agency (EMEA) considered PET
scans to be indicated for the diagnosis of chronic bone and
joint and adjacent infection including osteomyelitis, spon-
dylosis, discitis or osteitis including presence of metallic
implants.147
When compared to leukocyte scans, PET is considerably
quicker, typically requiring only 2–3 h. There is lower
radiation exposure and reduced costs.148,149 Most impor-
tantly, information gathered from PET/CT scans is
three-dimensional. The anatomical location of infection is
accurately defined. FDG uptake showing moderately raised
maximum standardized uptake value circumscribing metal-
lic implants is usually diagnostic of OAI. The images are
minimally distorted by metal artefacts. Furthermore, spatial
resolution is superior to both leukocyte scans and single
photon emission CT. Serial FDG-PET is demonstrated to
be useful in monitoring progress.150,151 With appropriate
use of PET scans, infections can be accurately detected
where timely surgical treatment can be more appropriately
initiated.152 In very early stages of infection, surgical deb-
ridement may be totally avoided by early initiation of anti-
biotics.149 Currently, the optimal diagnostic criteria of OAI
in PET remain to be studied and accurately defined. False
positive exams can rarely occur from acute fracture healing
and early post-operative inflammation especially within the
first 6 weeks after osteosynthesis.
Blood tests
There is robust data to support routine checking of leuko-
cyte count, erythrocyte sedimentation rate (ESR) and
C-reactive protein level (CRP) in OAI cases. In non-
unions with suspected infection, the positive predictive
value is 100, 56 and 18%, respectively, when three, two
and one of the tests are abnormally elevated. In excluding
infection, the negative predictive value is 81.6% when all
four results are normal.146
The CRP usually peaks on the second post-operative day
and normalizes after 2–3 weeks.153 A persistently raised
CRP beyond 4 to 7 days after surgery raises the suspicion
of infection.154 ESR has high sensitivity but suffers from a
long half-life of around 6 weeks and is, therefore, less
specific. Serial ESR and CRP levels are very useful in
monitoring treatment progress in patients with established
OAI. Serum IL-6 levels have a short half-life and have been
studied as a possible sensitive and specific alternative to
CRP.155,156 Unfortunately, IL-6 levels are more prone to an
elevation in response to major trauma or surgery and still
less specific than CRP.157
Blood cultures should be routinely obtained before sur-
gical treatment. Patients with clinical sepsis have higher
yields than those without. False positives due to contami-
nation may be minimized by obtaining two sets of blood
culture from two different sites at separate time intervals.
Immunocompromised patients with bacteraemia should be
suspected to have distant seeding at multiple sites espe-
cially when there are multiple implants.
Local samples
Superficial swabs are less sensitive than bone, tissue or
fluid specimens and should be interpreted together with
clinical features.158 Superficial swabs are neither sensitive
nor specific in chronic wounds and sinus tracts, because
contamination and colonization are usual.159
Aspiration of peri-implant collection for culture and
susceptibility testing is relatively simple. Before surgical
intervention, the procedure is performed using aseptic tech-
nique under clinical or image guidance. Unless in clinical
sepsis, antibiotics should be withheld for 2 weeks before
specimen collection.
Exploration and debridement can establish the diagnosis
when the local and systemic clinical features, laboratory
findings and radiological pictures are inconclusive. A com-
prehensive set of specimens, including peri-implant soft
tissues, callus and bone, should collect routinely at sur-
gery.160 Necrotic and infected materials typically provide
higher yields. Sequestrum may harbour slow-growing
organisms. Fluids such as joint fluid, pus, infected haema-
toma or sanguineous collections can be injected into blood
culture bottles to improve the recovery of slow-growing
microbes. A larger volume of specimen increases the yield.
Histological examination is complimentary to microbio-
logical tests, because infection presents with specific pat-
terns of inflammatory response, leukocyte migration,
abscess and tissue necrosis. Atypical low-grade pathogens
such as fungus or mycobacterium are sometimes only iden-
tifiable through histology.161 Antibiotic susceptibility tests
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are routine. Clinicians should liaise with the microbiology
laboratory for testing of additional antibiotics if
necessary.162
Culture-negative infections
There are several reasons for negative culture results in
patients with suspected OAI, the most common of which
is the prior use of antimicrobials. Other common factors
include insufficient microbiological testing, inadequate
quantity of specimens, failure to obtain the representative
samples and use of non-routine or unfamiliar testing pro-
tocols. Negative cultures may also result from infections by
fastidious organisms or organisms that cannot be cultured.
Finally, the clinical situation may not be an infection, but
rather an allergic implant material reaction or other scenar-
ios clinically indistinguishable from infection.163
Mechanical scraping of implants is ineffective in dislod-
ging microorganisms.164,165 Fluid bath sonification of
retrieved implants has a sensitivity of 90.4% in OAI166 and
an 18–30% increase in pickup rate compared to conven-
tional cultures in implant infections.162,166–168 The sonifi-
cation equipment uses low-frequency ultrasound to detach
biofilm-bound organisms by the formation of transient
microscopic bubbles on the implant surface. The process
is performed in lactated Ringer’s solution. Vortex mixing,
centrifugation169 and inoculation of the sonicated fluid in
blood culture bottles170 appear to further improve the diag-
nostic yield.
While laboratory bacterial culture remains standard, mole-
cular diagnosis by polymerase chain reaction (PCR) of spe-
cific genes can identify suspected organisms in 9–85% of
culture negative orthopaedic implant infections.171–176
The broad range PCR can detect a broad variety of organ-
isms with known sequences of the 16s-rRNA gene. A pos-
itive test would have a concordance rate of around 90%
with positive laboratory cultures. Sensitivity may be fur-
ther improved by using sonicate fluid171 and additionally
performing pathogen-specific PCR against common
pathogens such as S. aureus.176 In PCR, slower growing
organisms such as Propionibacterium acnes are increas-
ingly identified.174 The sensitivity of the test varied widely
between studies but is thought to dependent on the number
of pre-determined organisms in the genome database and
secondly following strict handling procedures. PCR has a
number of limitations, including proneness to contamina-
tion, high equipment costs, lack of quantitative assess-
ments, lack of information on antibiotic susceptibility
and difficulty in picking up polymicrobial infections. For
best cost-effectiveness, PCR test should be reserved for
culture negative cases only.
Classification
OAI may be classified according to the route of infection,
the onset of symptoms after implantation, fracture stability,
union status, location, the extent of infection and host sta-
tus.177 Romano`178 proposed a seven-item classification,
which simultaneously considered clinical presentation,
aetiology, anatomical location, host-type, microorganism,
bone defect and soft tissue defect. So far, the system has not
been widely adopted and yet no other classification system
appeared sufficiently precise and comprehensive.
According to time after surgery
Chronological classification of OAI is preferred, because it
gives guidance on the treatment strategy.20 Early or acute
infections (within 2 weeks after implantation) are most
common and associated with virulent organisms, such S.
aureus, aerobic gram-negative bacilli or Streptococcus
pyogenes.80 Fortunately, organisms at an early stage are
susceptible to antibiotics and associated with less biofilm
and sequestrum formation.
Delayed infections (3–10 weeks after implantation) are
associated with moderate or less virulent skin flora such S.
aureus or CNS. Late infections (>10 weeks after implanta-
tion) are commonly associated with delayed diagnosis.
Typical organisms are S. Aureus, S. epidermidis and Pseu-
domonas aeruginosa.80,179 Delayed and late infections are
harder to eradicate due to the presence of biofilm, seques-
trum and microbial resistance. Reactivation due to the con-
tinuous bacterial residence after successful treatment is
common.90,180 Management is complicated when there are
implant loosening and incomplete union. This will be dis-
cussed in the second part of this article (Figure 2).
According to route of infection
The route of infection can be exogenous, contiguous or
haematogenous.6,181 Direct exogenous inoculation is most
common and is associated with adverse wound factors.
Contiguous spread of an adjacent local infection, such as
cellulitis or a nearby septic joint and haematogenous seed-
ing from distant sites, is relatively less often compared to
PJI.182,183 It is important to note whether the patient has
other foci of infection especially for immunocompromised
hosts and those with prosthetic devices.184
According to fracture healing
The concern for fracture healing is unique in OAI.
Romano`178 proposed a three-category classification based
on stability and callus formation. In type I infections, there
is stable osteosynthesis and progressive callus formation.
Cases may be treated non-operatively with antibiotics and
allowing time until union. In type II infections, there is
stable osteosynthesis but scarce or absent callus progres-
sion. Stability must be maintained, and hardware can be
retained. Infection is controlled surgically and with drugs.
Bone healing is accelerated through physical stimulation
and biological factors. In type III infections, osteosynthesis
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is unstable, hardware revision or external fixation is
required in addition to above.
According to clinical severity
Many studies classify infections as superficial or deep.
Superficial infections are usually early infections, only
affecting the overlying soft tissue without collection and
osteomyelitis. The definition is controversial, because
superficial surgical wounds are nearly always connected
to the deep unless the fascial barrier in between is water
tight. The so-called milder form of ‘superficial infection’ is
less common than deep infection according to a prospective
multicenter study of hip fractures.76 Superficial infections
are clinically indistinguishable from deep one in locations
with thin soft tissue envelope such as near the ankle.185
Some classifications considered the presence of an active
sinus186 and size of bone defects187,188 to grade clinical
severity and guide management.
According to host type
Host immunity and physiological status are an important
factor in surgical decision-making. The systems proposed
by Cierny189 and McPherson190 classify hosts into types A,
B and C. Type A hosts have no significant local adverse
factors or medical comorbidities and healthy immune
response, metabolism and vascularity of the infected area.
Type B hosts have one or two significant local or systemic
adverse factors, and Type C hosts either have three or more
adverse factors or are medically too unwell to undergo
surgery. Type C patients are most immunocompromised
and unlikely to benefit from multiple stages of surgery,
so either drug suppression therapy or amputation is consid-
ered. The downgrading of hosts to a more favourable status
is possible by control of systemic and local adverse factors
(Table 1).
Summary
We have discussed the risk factors, pathogenesis, diagnos-
tic and classification considerations of OAI above. Stability
of the fracture appears to be highly relevant. Despite some
adverse effects of implants, their maintenance may be ben-
eficial, because stability imparts better overall control of
infection. The absence of a rapid, simple and reliable pro-
tocol for diagnosis and the lack of consensus in classifica-
tion is where further research is needed. Understanding the
fundamentals above is essential in formulating preventive
and treatment tactics. The management of OAI will be
discussed in the second part of this article.
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Figure 2. A 76-year-old lady suffering from CNS infection of the proximal humerus 6 weeks from fixation. Infection was controlled
with debridement, implant removal, suture stabilization of the tuberosities, immobilization and 4 weeks of antibiotics. Despite healing,
the glenohumeral joint was destroyed with only 90 of shoulder elevation. The presentation of this patient can be classified as a delayed
infection. CNS: coagulase-negative staphylococci. Note: the extensive periosteal reaction and failure of fixation.
Table 1. Systemic and local factors that affect local immunity,
metabolism and vascularity in the host physiological
classification system adopted from Cierny et al.189
Adverse factors affecting immunity, metabolism and local
vascularity
Systemic Local
Malnutrition Chronic lymphedema
Renal, liver failure Venous stasis
Alcohol abuse Major vessel compromise
Immune deficiency Arteritis
Chronic hypoxia Extensive scarring
Malignancy Radiation fibrosis
Diabetes mellitus
Extremes of age
Steroid therapy
Tobacco abuse
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